This therapeutic approach holds promising clinical significance, since studies have proved that Carotuximab is safe and effective in the clinical treatment of glioma [45, 46] and blocking TGFβ pathway in astrocytes holds promise for treating AD [62, 65]. The gene discussed is TGFB1; the disease is glioma.